article thumbnail

Process improvements and in-person monitoring help U.S. pharmaceutical company achieve on time for Phase III clinical trials

Impact Pharmaceutical Services

Process improvements and in-person monitoring by Syner-G helped the client to get the DS with the right quality and quantity on time for Phase III clinical trials. Download The Case Study The post Process improvements and in-person monitoring help U.S.

article thumbnail

ADCs Reap the Benefits of Continual Research and Process Improvements

BioPharm

Deeper biological understanding and technology innovations have improved the fate of ADC development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Seed Train Intensification Using High Cell Density Cryopreservation and Specially-designed Expansion Medium

BioPharm

We explore seed train intensification approaches which deliver significant upstream process improvements in speed, flexibility and reliability.

article thumbnail

Single-use technology propelling upstream bioprocessing market expansion

European Pharmaceutical Review

The authors also noted that growth of the upstream bioprocessing market is being pushed by the need for process improvement, and because “processing equipment consumption has expanded”.

article thumbnail

Leveraging Data for Predictive & Real-time Bioprocess Performance Improvements

BioPharm

Thu, Sep 8, 2022 11am EST | 8am PST | 4pm BST | 5pm CEST Digitalization & leveraging real-time data are key for biopharma process improvement. Insilico models and soft-sensors boost biopharma performance to unprecedented levels.

article thumbnail

Pharmacy’s digital transformation spotlighted in new FIP report

Hospital Pharmacy Europe

Digital advancements have the potential to revolutionise hospital pharmacy by streamlining processes, improving medication safety and enhancing patient care, a new report from the International Pharmaceutical Federation (FIP) has concluded.

article thumbnail

XtalPi and CK Life Sciences to develop AI-driven tumour vaccine R&D platform

Pharmaceutical Technology

CK Life Sciences vice-president and chief scientific officer Dr Melvin Toh said: “The cooperation with XtalPi will apply XtalPi’s AI algorithm, molecular modelling and automated experiments to speed up the R&D process, improve the success rate, and increase the efficacy of tumour vaccines.”.